Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer.

  • Cryopreservation, Journal Articles

Podrazil M, Horvath R, Becht E, et al. Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer. (2015). Oncotarget, 5, 17891-17904.  DOI: 10.18632/oncotarget.4145

Date

BioLife Solutions logo

This website uses cookies to ensure you get the best experience on our website.

Accept & close